← Leaderboards
Cary Nathaniel Weiss
Albert Einstein College Of Medicine, Inc
$194,333
Attributed
$194,333
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.5K · FY2016–19$50K$37.5K$25K$12.5K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$194,333 · 1
By mechanism
F30$194,333 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine, Inc
Same institution · by research overlap
- Meelad Dawlaty$5,115,464
- Richard Piszczatowski$201,096
- Joshua Weinreb$201,096
- David R Fooksman$5,738,037
- Justin Chyles Wheat$148,092
Others in their field
Top investigators on “Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Peter J. Snyder · University Of Pennsylvania$35,309,252
- Jeffrey Lee Carson · Univ Of Med/Dent Nj-R W Johnson Med Sch$29,495,757
- Michael L. Terrin · Clinical Trials And Surveys Corporation$26,727,584
- Leonard I Zon · Children'S Hospital Boston$26,660,149
Research focus
AnemiaAcute Myelocytic LeukemiaBaseBlood CellsAzacitidineCell TypeChromatin RemodelingCytosineDecitabineDefectDioxygenasesCellsDna MethylationDna Modification MethylasesDysmyelopoietic SyndromesDysplasiaElderlyEpigenetic ProcessEpigenetic RegulationExcisionFailureGene ExpressionGenesGenome-Wide
Grant awards (5)
microRNA-22 and the microRNA-22/TET2 Network as Regulators of the Cell Fate Decision in Hematopoietic Stem Cells and in the Development of Myelodysplastic Syndrome.$47,189
F30 · FY2019 · DK · contact PI
microRNA-22 and the microRNA-22/TET2 Network as Regulators of the Cell Fate Decision in Hematopoietic Stem Cells and in the Development of Myelodysplastic Syndrome.$25,193
F30 · FY2018 · DK · contact PI
microRNA-22 and the microRNA-22/TET2 Network as Regulators of the Cell Fate Decision in Hematopoietic Stem Cells and in the Development of Myelodysplastic Syndrome.$24,331
F30 · FY2018 · DK · contact PI
microRNA-22 and the microRNA-22/TET2 Network as Regulators of the Cell Fate Decision in Hematopoietic Stem Cells and in the Development of Myelodysplastic Syndrome.$49,044
F30 · FY2017 · DK · contact PI
microRNA-22 and the microRNA-22/TET2 Network as Regulators of the Cell Fate Decision in Hematopoietic Stem Cells and in the Development of Myelodysplastic Syndrome.$48,576
F30 · FY2016 · DK · contact PI